{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:28:08Z","timestamp":1774686488050,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/bf03346699","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T18:06:22Z","timestamp":1396029982000},"page":"78-84","source":"Crossref","is-referenced-by-count":46,"title":["Environmental triggers of thyroiditis: Hepatitis C and interferon-\u03b1"],"prefix":"10.1007","volume":"34","author":[{"given":"F.","family":"Menconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hasham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346699_CR1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","volume":"29","author":"A Huber","year":"2008","unstructured":"Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008, 29: 697\u2013725.","journal-title":"Endocr Rev"},{"key":"BF03346699_CR2","first-page":"930","volume":"86","author":"TH Brix","year":"2001","unstructured":"Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves\u2019 disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001, 86: 930\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1568-9972(01)00016-7","volume":"1","author":"NR Rose","year":"2002","unstructured":"Rose NR, Bonita R, Burek CL Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 2002, 1: 97\u2013103.","journal-title":"Autoimmun Rev"},{"key":"BF03346699_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaut.2007.01.001","volume":"28","author":"HS Li","year":"2007","unstructured":"Li HS, Jiang HY, Carayanniotis G. Modifying effects of iodine on the immunogenicity of thyroglobulin peptides. J Autoimmun 2007, 28: 171\u20136.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2004.03.003","volume":"3","author":"Y Oppenheim","year":"2004","unstructured":"Oppenheim Y, Ban Y, Tomer Y. Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity. Autoimmun Rev 2004, 3: 388\u201393.","journal-title":"Autoimmun Rev"},{"key":"BF03346699_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0950-351X(95)80819-1","volume":"9","author":"Y Tomer","year":"1995","unstructured":"Tomer Y, Davies TF. Infections and autoimmune endocrine disease. Baillieres Clin Endocrinol Metab 1995, 9: 47\u201370.","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"BF03346699_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","volume":"32","author":"Y Tomer","year":"2009","unstructured":"Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009, 32: 231\u20139.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ecl.2007.07.001","volume":"36","author":"Y Tomer","year":"2007","unstructured":"Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 2007, 36: 1051\u201366.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF03346699_CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaut.2009.09.001","volume":"33","author":"CL Burek","year":"2009","unstructured":"Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009, 33: 183\u20139.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM198001033020105","volume":"302","author":"AK Bahn","year":"1980","unstructured":"Bahn AK, Mills JL, Snyder PJ, et al. Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med 1980, 302: 31\u20133.","journal-title":"N Engl J Med"},{"key":"BF03346699_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-6-5","volume":"6","author":"R Desailloud","year":"2009","unstructured":"Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J 2009, 6: 5.","journal-title":"Virol J"},{"key":"BF03346699_CR12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hep.510260127","volume":"26","author":"M Deutsch","year":"1997","unstructured":"Deutsch M, Dourakis S, Manesis EK, et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 1997, 26: 206\u201310.","journal-title":"Hepatology"},{"key":"BF03346699_CR13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/er.2002-0030","volume":"24","author":"Y Tomer","year":"2003","unstructured":"Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 2003, 24: 694\u2013717.","journal-title":"Endocr Rev"},{"key":"BF03346699_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","volume":"43","author":"JC Mandac","year":"2006","unstructured":"Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 2006, 43: 661\u2013672.","journal-title":"Hepatology"},{"key":"BF03346699_CR15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2796.2002.00974.x","volume":"251","author":"O Dalgard","year":"2002","unstructured":"Dalgard O, Bjoro K, Hellum K, et al. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med 2002, 251: 400\u20136.","journal-title":"J Intern Med"},{"key":"BF03346699_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","volume":"13","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Laurberg P. Interferon-alpha and autoimmune thyroid disease. Thyroid 2003, 13: 547\u201351.","journal-title":"Thyroid"},{"key":"BF03346699_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0960-0760(91)90287-F","volume":"40","author":"CJ Grossman","year":"1991","unstructured":"Grossman CJ, Roselle GA, Mendenhall CL Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol 1991, 40: 649\u201359.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF03346699_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.05.006","volume":"29","author":"Y Tomer","year":"2007","unstructured":"Tomer Y, Menconi F, Davies TF, et al. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun 2007, 29: 69\u201377.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaut.2007.02.016","volume":"28","author":"Y Ban","year":"2007","unstructured":"Ban Y, Tozaki T, Tobe T, et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts. J Autoimmun 2007, 28: 201\u20137.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR20","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1210\/jc.2008-0364","volume":"93","author":"Y Ban","year":"2008","unstructured":"Ban Y, Greenberg DA, Davies TF, Jacobson E, Concepcion E, Tomer Y. Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease. J Clin Endocrinol Metab 2008, 93: 3589\u201396.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR21","doi-asserted-by":"crossref","unstructured":"Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995. 43: 55\u20136","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"BF03346699_CR22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","volume":"101","author":"E Roti","year":"1996","unstructured":"Roti E, Minelli R, Giuberti T, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996, 101: 482\u20137.","journal-title":"Am J Med"},{"key":"BF03346699_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10446670310001642177","volume":"10","author":"Y Oppenheim","year":"2003","unstructured":"Oppenheim Y, Kim G, Ban Y, et al. The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse. Clin Dev Immunol 2003, 10: 161\u20135.","journal-title":"Clin Dev Immunol"},{"key":"BF03346699_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","volume":"30","author":"EM Jacobson","year":"2008","unstructured":"Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology. J Autoimmun 2008, 30: 58\u201362.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","volume":"28","author":"EM Jacobson","year":"2007","unstructured":"Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future. J Autoimmun 2007, 28: 85\u201398.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0168-8278(99)80131-7","volume":"30","author":"S Kakizaki","year":"1999","unstructured":"Kakizaki S, Takagi H, Murakami M, Takayama H, Mori M. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol 1999, 30: 794\u2013800.","journal-title":"J Hepatol"},{"issue":"1","key":"BF03346699_CR27","first-page":"221","volume":"7","author":"W Kryczka","year":"2001","unstructured":"Kryczka W, Brojer E, Kowalska A, Zarebska-Michaluk D. Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C. Med Sci Monit 2001, 7 (Suppl 1): 221\u20135.","journal-title":"Med Sci Monit"},{"key":"BF03346699_CR28","first-page":"926","volume":"16","author":"EM Jacobson","year":"2006","unstructured":"Jacobson EM, Chaudhry S, Mandac JC, Concepcion E, Tomer Y. Immune-regulatory gene involvement in the etiology of interferon induced thyroiditis (IIT). Thyroid 2006, 16: 926 (Meeting Abstract).","journal-title":"Thyroid"},{"key":"BF03346699_CR29","doi-asserted-by":"crossref","unstructured":"Tomer Y, Villanueva R. Hepatitis C and thyroid autoimmunity: is there a link? Am J Med 2004, 117: 60\u201369","DOI":"10.1016\/j.amjmed.2004.04.004"},{"key":"BF03346699_CR30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","volume":"117","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004, 117: 10\u20133.","journal-title":"Am J Med"},{"key":"BF03346699_CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00686.x","volume":"50","author":"MJ Huang","year":"1999","unstructured":"Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol (Oxf) 1999, 50: 503\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346699_CR32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2893.2005.00699.x","volume":"13","author":"A Floreani","year":"2006","unstructured":"Floreani A, Betterle C, Carderi I, Presotto F, Pedini B, Moscon A et al. Is hepatitis C virus a risk factor for thyroid autoimmunity? J Viral Hepat 2006, 13: 272\u20137.","journal-title":"J Viral Hepat"},{"key":"BF03346699_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/jaut.1999.0360","volume":"14","author":"N Ganne-Carrie","year":"2000","unstructured":"Ganne-Carrie N, Medini A, Coderc E, et al. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun 2000, 14: 189\u201393.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1413-86702008000200009","volume":"12","author":"LJ Andrade","year":"2008","unstructured":"Andrade LJ, Atta AM, D\u2019Almeida Junior A, Paran\u00e1 R. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin\u2014a review. Braz J Infect Dis 2008, 12: 144\u20138.","journal-title":"Braz J Infect Dis"},{"key":"BF03346699_CR35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4158\/EP.7.1.52","volume":"7","author":"DL Ward","year":"2001","unstructured":"Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract 2001, 7: 52\u20138.","journal-title":"Endocr Pract"},{"key":"BF03346699_CR36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.2006.16.563","volume":"16","author":"A Antonelli","year":"2006","unstructured":"Antonelli A, Ferri C, Fallahi P, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006, 16: 563\u201372.","journal-title":"Thyroid"},{"key":"BF03346699_CR37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/eje.0.1420431","volume":"142","author":"MC Hsieh","year":"2000","unstructured":"Hsieh MC, Yu ML, Chuang WL, et al. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 2000, 142: 431\u20137.","journal-title":"Eur J Endocrinol"},{"key":"BF03346699_CR38","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jmv.21269","volume":"80","author":"J Bartolome","year":"2008","unstructured":"Bartolome J, Rodriguez-Inigo E, Quadros P, et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 2008, 80: 1588\u201394.","journal-title":"J Med Virol"},{"key":"BF03346699_CR39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","volume":"31","author":"N Akeno","year":"2008","unstructured":"Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 2008, 31: 339\u201344.","journal-title":"J Autoimmun"},{"key":"BF03346699_CR40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","volume":"23","author":"Y Tomer","year":"2009","unstructured":"Tomer Y, Menconi F. Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab 2009, 23: 703\u201312.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BF03346699_CR41","first-page":"2489","volume":"58","author":"LM Pfeffer","year":"1998","unstructured":"Pfeffer LM, Dinarello CA, Herberman RB, et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 1998, 58: 2489\u201399.","journal-title":"Cancer Res"},{"key":"BF03346699_CR42","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347: 975\u201382.","journal-title":"N Engl J Med"},{"key":"BF03346699_CR43","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","volume":"124","author":"MW Russo","year":"2003","unstructured":"Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003, 124: 1711\u20139.","journal-title":"Gastroenterology"},{"key":"BF03346699_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpg.2009.10.012","volume":"24","author":"F Negro","year":"2010","unstructured":"Negro F. Adverse effects of drugs in the treatment of viral hepatitis. Best Pract Res Clin Gastroenterol 2010, 24: 183\u201392.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"BF03346699_CR45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/jc.2004-1173","volume":"90","author":"N Caraccio","year":"2005","unstructured":"Caraccio N, Giannini R, Cuccato S, Faviana P, Berti P, Galleri D et al. Type I interferons modulate the expression of thyroid peroxidase, sodium\/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures. J Clin Endocrinol Metab 2005, 90: 1156\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/thy.2008.0290","volume":"19","author":"N Caraccio","year":"2009","unstructured":"Caraccio N, Cuccato S, Pratesi F, Dardano A, Ursino S, Chimenti D et al. Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. Thyroid 2009, 19: 149\u201355.","journal-title":"Thyroid"},{"key":"BF03346699_CR47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22070","volume":"47","author":"RT Chung","year":"2008","unstructured":"Chung RT, Gale M Jr, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop. Hepatology 2008, 47: 306\u201320.","journal-title":"Hepatology"},{"key":"BF03346699_CR48","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005, 436: 967\u201372.","journal-title":"Nature"},{"key":"BF03346699_CR49","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999000750053690","volume":"20","author":"EP Corssmit","year":"2000","unstructured":"Corssmit EP, de Metz J, Sauerwein HP, Romijn JA. Biologic responses to IFN-alpha administration in humans. J Interferon Cytokine Res 2000, 20: 1039\u201347.","journal-title":"J Interferon Cytokine Res"},{"key":"BF03346699_CR50","first-page":"61","volume":"112","author":"X You","year":"1999","unstructured":"You X, Teng W, Shan Z. Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha. Chin Med J (Engl) 1999, 112: 61\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"BF03346699_CR51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2249.1996.d01-784.x","volume":"105","author":"RA Ajjan","year":"1996","unstructured":"Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto\u2019s thyroiditis. Clin Exp Immunol 1996, 105: 523\u20138.","journal-title":"Clin Exp Immunol"},{"key":"BF03346699_CR52","first-page":"265","volume":"61","author":"I Todd","year":"1985","unstructured":"Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldmann M. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985, 61: 265\u201373.","journal-title":"Clin Exp Immunol"},{"key":"BF03346699_CR53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0167-5699(00)01710-2","volume":"21","author":"JD Farrar","year":"2000","unstructured":"Farrar JD, Murphy KM. Type I interferons and T helper development. Immunol Today 2000, 21: 484\u20139.","journal-title":"Immunol Today"},{"key":"BF03346699_CR54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000184606","volume":"44","author":"C Carella","year":"1995","unstructured":"Carella C, Amato G, Biondi B, et al. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res 1995, 44: 110\u20134.","journal-title":"Horm Res"},{"key":"BF03346699_CR55","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1210\/en.2004-0352","volume":"145","author":"KJ Land","year":"2004","unstructured":"Land KJ, Moll JS, Kaplan MH, Seetharamaiah GS. Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves\u2019 hyperthyroidism. Endocrinology 2004, 145: 3724\u201330.","journal-title":"Endocrinology"},{"key":"BF03346699_CR56","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1210\/jc.2005-0093","volume":"90","author":"G Mazziotti","year":"2005","unstructured":"Mazziotti G, Sorvillo F, Piscopo M, et al. Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study. J Clin Endocrinol Metab 2005, 90: 4138\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR57","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.170.7.3522","volume":"170","author":"Y Nagayama","year":"2003","unstructured":"Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B. Prevention of autoantibody-mediated Graves\u2019-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J Immunol 2003, 170: 3522\u20137.","journal-title":"J Immunol"},{"key":"BF03346699_CR58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.1997.269-ce1161.x","volume":"107","author":"EP Corssmit","year":"1997","unstructured":"Corssmit EP, Heijligenberg R, Hack CE, Endert E, Sauerwein HP, Romijn JA. Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol 1997, 107: 359\u201363.","journal-title":"Clin Exp Immunol"},{"key":"BF03346699_CR59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(03)00390-5","volume":"115","author":"I Krause","year":"2003","unstructured":"Krause I, Valesini G, Scrivo R, Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am J Med 2003, 115: 390\u20137.","journal-title":"Am J Med"},{"key":"BF03346699_CR60","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1073\/pnas.70.10.2785","volume":"70","author":"P Lindahl","year":"1973","unstructured":"Lindahl P, Leary P, Gresser I. Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci U S A 1973, 70: 2785\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BF03346699_CR61","unstructured":"Akeno N, Tomer Y. Dissecting the mechanisms of interferon induced thyroiditis (IIT): Direct effects of interferon alpha on thyroid epithelial cells. The 89th Meeting of the Endocrine Society, Toronto, Canada, June 2007."},{"key":"BF03346699_CR62","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(85)92475-4","volume":"1","author":"IS Fentiman","year":"1985","unstructured":"Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985, 1: 1166.","journal-title":"Lancet"},{"key":"BF03346699_CR63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR64","first-page":"922","volume":"80","author":"A Imagawa","year":"1995","unstructured":"Imagawa A, Itoh N, Hanafusa T, et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 1995, 80: 922\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR65","first-page":"399","volume":"89","author":"U Watanabe","year":"1994","unstructured":"Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994, 89: 399\u2013403.","journal-title":"Am J Gastroenterol"},{"key":"BF03346699_CR66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1320587","volume":"132","author":"D Preziati","year":"1995","unstructured":"Preziati D, La Rosa L, Covini G, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 1995, 132: 587\u201393.","journal-title":"Eur J Endocrinol"},{"key":"BF03346699_CR67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000184606","volume":"44","author":"C Carella","year":"1995","unstructured":"Carella C, Amato G, Biondi B et al. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res 1995, 44: 110\u20134.","journal-title":"Horm Res"},{"key":"BF03346699_CR68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1996","unstructured":"Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 1996, 44: 635\u201342.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346699_CR69","first-page":"1925","volume":"86","author":"C Carella","year":"2001","unstructured":"Carella C, Mazziotti G, Morisco F, et al. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 2001, 86: 1925\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR70","first-page":"49","volume":"22","author":"A Martocchia","year":"2001","unstructured":"Martocchia A, Labbadia G, Paoletti V, et al. Hashimoto\u2019s disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease. Neuro Endocrinol Lett 2001, 22: 49\u201352.","journal-title":"Neuro Endocrinol Lett"},{"key":"BF03346699_CR71","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","volume":"39","author":"E Baudin","year":"1993","unstructured":"Baudin E, Marcellin P, Pouteau M, et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf) 1993, 39: 657\u201361.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346699_CR72","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.1997.7.891","volume":"7","author":"LK Koh","year":"1997","unstructured":"Koh LK, Greenspan FS, Yeo PP. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997, 7: 891\u20136.","journal-title":"Thyroid"},{"key":"BF03346699_CR73","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2002.01553.x","volume":"56","author":"V Wong","year":"2002","unstructured":"Wong V, Fu AX, George J, Cheung NW. Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin Endocrinol (Oxf) 2002, 56: 793\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346699_CR74","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","volume":"102","author":"M Lisker-Melman","year":"1992","unstructured":"Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 1992, 102: 2155\u201360.","journal-title":"Gastroenterology"},{"key":"BF03346699_CR75","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","volume":"89","author":"C Carella","year":"2004","unstructured":"Carella C, Mazziotti G, Amato G, Braverman LE, Roti E. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab 2004, 89: 3656\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346699_CR76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/qjmed\/hcp157","volume":"103","author":"HA Tran","year":"2010","unstructured":"Tran HA. The swinging thyroid in hepatitis C infection and interferon therapy. QJM 2010, 103: 187\u201391.","journal-title":"QJM"},{"key":"BF03346699_CR77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/eje.1.02104","volume":"154","author":"NL Bohbot","year":"2006","unstructured":"Bohbot NL, Young J, Orgiazzi J, et al. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves\u2019 disease. Eur J Endocrinol 2006, 154: 367\u201372.","journal-title":"Eur J Endocrinol"},{"key":"BF03346699_CR78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrgastro.2009.168","volume":"6","author":"A Antonelli","year":"2009","unstructured":"Antonelli A, Ferri C, Fallahi P. Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy. Nat Rev Gastroenterol Hepatol 2009, 6: 633\u20135.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BF03346699_CR79","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2010.05.009","volume":"141","author":"K Cadwell","year":"2010","unstructured":"Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn\u2019s disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141: 1135\u201345.","journal-title":"Cell"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346699.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346699\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:18:22Z","timestamp":1565299102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BF03346699"],"URL":"https:\/\/doi.org\/10.1007\/bf03346699","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}